These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34303830)

  • 1. Whole exome sequencing identified FAM149A as a plausible causative gene for congenital hereditary endothelial dystrophy, affecting Nrf2-Antioxidant signaling upon oxidative stress.
    Zhang J; Dai Y; Wu D; Li Y; Xu J
    Free Radic Biol Med; 2021 Sep; 173():117-124. PubMed ID: 34303830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC4A11 depletion impairs NRF2 mediated antioxidant signaling and increases reactive oxygen species in human corneal endothelial cells during oxidative stress.
    Guha S; Chaurasia S; Ramachandran C; Roy S
    Sci Rep; 2017 Jun; 7(1):4074. PubMed ID: 28642546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy.
    Patel SP; Parker MD
    Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and Function Analysis of Two Novel SLC4A11 Variants in Patients With Congenital Hereditary Endothelial Dystrophy.
    Zhen T; Li Y; Guo Q; Yao S; You Y; Lei B
    Transl Vis Sci Technol; 2023 Oct; 12(10):1. PubMed ID: 37787991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observation of nine previously reported and 10 non-reported
    Moazzeni H; Javadi MA; Asgari D; Khani M; Emami M; Moghadam A; Panahi-Bazaz MR; Hosseini Tehrani M; Karimian F; Hosseini B; Nekuie Moghadam T; Hassanpour H; Akbari MT; Elahi E
    Br J Ophthalmol; 2020 Nov; 104(11):1621-1628. PubMed ID: 31420327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani families.
    Firasat S; Dur-E-Shawar ; Khan WA; Sughra U; Nousheen ; Kaul H; Naz S; Noreen B; Gul R; Afshan K
    Mol Biol Rep; 2021 Nov; 48(11):7467-7476. PubMed ID: 34637099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of novel mutations of SLC4A11 gene in patients with congenital hereditary endothelial dystrophy].
    Li Y; Zhang J; Xu JJ
    Zhonghua Yan Ke Za Zhi; 2021 Feb; 57(2):133-138. PubMed ID: 33541055
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexistence of Congenital Hereditary Endothelial Dystrophy and Fuchs Endothelial Corneal Dystrophy Associated With SLC4A11 Mutations in Affected Families.
    Chaurasia S; Ramappa M; Annapurna M; Kannabiran C
    Cornea; 2020 Mar; 39(3):354-357. PubMed ID: 31714402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy.
    Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M
    Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the functional impact of CHED- and FECD4-associated SLC4A11 mutations in human corneal endothelial cells.
    Chung DD; Chen AC; Choo CH; Zhang W; Williams D; Griffis CG; Bonezzi P; Jatavallabhula K; Sampath AP; Aldave AJ
    PLoS One; 2024; 19(1):e0296928. PubMed ID: 38252645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuchs Endothelial Corneal Dystrophy in a Heterozygous Carrier of Congenital Hereditary Endothelial Dystrophy Type 2 with a Novel Mutation in SLC4A11.
    Kim JH; Ko JM; Tchah H
    Ophthalmic Genet; 2015; 36(3):284-6. PubMed ID: 24502824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome.
    Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M
    Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous mutations in the
    Liu M; Xia JL; Yang H; Yu L
    Ophthalmic Genet; 2022 Aug; 43(4):538-542. PubMed ID: 35291925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2).
    Vithana EN; Morgan P; Sundaresan P; Ebenezer ND; Tan DT; Mohamed MD; Anand S; Khine KO; Venkataraman D; Yong VH; Salto-Tellez M; Venkatraman A; Guo K; Hemadevi B; Srinivasan M; Prajna V; Khine M; Casey JR; Inglehearn CF; Aung T
    Nat Genet; 2006 Jul; 38(7):755-7. PubMed ID: 16767101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of SLC4A11 by tert-Butylhydroquinone is mediated by direct binding of Nrf2 to the promoter of SLC4A11.
    Guha S; Roy S
    Free Radic Biol Med; 2021 May; 167():299-306. PubMed ID: 33744340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional ion transport properties of human SLC4A11: comparison of the SLC4A11-B and SLC4A11-C variants.
    Kao L; Azimov R; Shao XM; Frausto RF; Abuladze N; Newman D; Aldave AJ; Kurtz I
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C820-C830. PubMed ID: 27581649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed onset of congenital hereditary endothelial dystrophy due to compound heterozygous SLC4A11 mutations.
    Kumawat BL; Gupta R; Sharma A; Sen S; Gupta S; Tandon R
    Indian J Ophthalmol; 2016 Jul; 64(7):492-5. PubMed ID: 27609159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC4A11 Three-Dimensional Homology Model Rationalizes Corneal Dystrophy-Causing Mutations.
    Badior KE; Alka K; Casey JR
    Hum Mutat; 2017 Mar; 38(3):279-288. PubMed ID: 27925686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial ROS Induced Lysosomal Dysfunction and Autophagy Impairment in an Animal Model of Congenital Hereditary Endothelial Dystrophy.
    Shyam R; Ogando DG; Choi M; Liton PB; Bonanno JA
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):15. PubMed ID: 34533563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy.
    Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.